EBV LMP2(HLA-A*0201)356-364

Supplier: peptides&elephants GmbH
Product Type: peptide
Description: Antigen Peptide EBV LMP2 HLA-A*0201 (FLYALALLL) for stimulation of human EBV LMP2(356-364)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. LYALALLL is a linear peptidic epitope studied as part of Latent membrane protein 2 from Human herpesvirus 4 (Epstein Barr virus). sterile and endotoxin free
Applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response .
Sequence: H-FLYALALLL-OH
Amount: 2x1 mg
Purity (HPLC): > 95%
Form: lyophilized as powder
Storage: -20°C